<img height="1" width="1" src="https://www.facebook.com/tr?id=1582471781774081&amp;ev=PageView &amp;noscript=1">

Acute Myeloid Leukemia PDX Models

Most commercially available blood cancer patient-derived xenograft (PDX) models are transient in nature, and non-transferable through passages (not renewable), without disease symptoms or mortality. However, Crown Bioscience’s PDX models for blood cancer are permanent, and allow the study of disease recurrence after initial treatment challenge and the efficacy testing of novel agents against drug resistance. The Crown Bioscience acute myeloid leukemia (AML) PDX collection consists of several models, including models with patient-relevant mutations e.g. FLT3(+), IDH2 mutation. More

PDX offer the most translational preclinical model for efficacy screening in cancer drug development. Derived directly from patient tumors and never adapted to grow in vitro, PDX models reflect the heterogeneity and diversity of the human patient population. PDX give you an accurate, predictive model of how your treatment will perform, well before entering into expensive clinical trials. CrownBio's HuPrime® PDX models are well characterized for pathology, growth characteristics, and are also genetically/genomically annotated for gene expression, gene copy number, mutations, and fusions.

MODEL NUMBER CANCER TYPE CANCER SUBTYPE DESCRIPTION # per page
AM5512 Acute Myeloid Leukemia N/A NA CLICK TO VIEW
AM7125 Acute Myeloid Leukemia N/A CLICK TO VIEW
AM7407 Acute Myeloid Leukemia N/A CLICK TO VIEW
AM7577 Acute Myeloid Leukemia M5 NA CLICK TO VIEW
AM7577 Acute Myeloid Leukemia N/A CLICK TO VIEW
AM8096 Acute Myeloid Leukemia N/A CLICK TO VIEW
AM8231 Acute Myeloid Leukemia N/A CLICK TO VIEW
AM9624 Acute Myeloid Leukemia N/A CLICK TO VIEW
AM9626 Acute Myeloid Leukemia N/A NA CLICK TO VIEW
AM9627 Acute Myeloid Leukemia N/A CLICK TO VIEW
AM9628 Acute Myeloid Leukemia N/A CLICK TO VIEW

Sorry, no posts matched your criteria.

Create Account to View All Model Data

Already Registered? Login